Profile changes in RNA, and protein expression in a single experiment. The Vantage 3D RNA:Protein Solid Tumor Assays are designed to provide a complete solid tumor profiling solution.
- Low sample inputs: as little as 25 ng RNA, and 250 ng protein or just 2 FFPE slides
- Comprehensive profiling of key biological targets in Solid Tumor research: up to 770 RNA, and 28 total and phospho-proteins
- Integrated RNA, and protein measurements eliminate the challenge of comparing data from different technologies
- Compatible with lysate and FFPE samples
Download the Application Note today: PDX Profiling.
Monitor targeted drug therapy response
Drug response to Vemurafenib (+/- Trametinib) was most pronounced in the homozygous BRAF V600E cell line yielding significant changes in gene and protein expression and intracellular phosphorylation state consistent with the mechanism of action of therapeutic kinase inhibitors.
Vantage 3D™ RNA:Protein Solid Tumor Assay for Lysate
| Feature | Specifications |
|---|---|
| Number of Targets | 770 RNA, 28 Proteins |
| Input Material | 1 µg protein |
| Sample Type(s) | Cell lysates or fresh/frozen tissue lysates |
| Species | Human |
| Time to Results | <48 hours |
| Data Analysis | nSolver™ Analysis software |
| Customize | Up to 5 additional protein targets |
| Shipping and Storage Conditions | -80°C |
Vantage 3D™ RNA:Protein Solid Tumor Assay for FFPE
| Feature | Specifications |
|---|---|
| Number of Targets | 770 RNA, 26 Protein |
| Input Material | 2 5 µM FFPE slides |
| Sample Type(s) | FFPE |
| Species | Human |
| Time to Results | <72 hours |
| Data Analysis | nSolver™ Analysis software |
| Customize | Up to 5 additional protein targets |
| Shipping and Storage Conditions | -80°C |
- Product Bulletin (RNA:Protein)
- Protein Data Normalization and Analysis
- Probe Lists
- nCounter® Vantage 3D™ RNA:Protein Solid Tumor Assay for Lysate
Includes 770 RNA probes (from the nCounter® PanCancer Pathways Panel) and 28 protein probes related to key cell signaling pathways in solid tumors, as well as 3 protein controls for background estimation and normalization. - nCounter® Vantage 3D™ RNA:Protein Solid Tumor Assay for FFPE
Includes 770 RNA probes (from the nCounter® PanCancer Pathways Panel) and 26 protein probes related to key cell signaling pathways in solid tumors, as well as 3 protein controls for background estimation and normalization.
- nCounter® Vantage 3D™ RNA:Protein Solid Tumor Assay for Lysate
Vantage 3D™ RNA:Protein Solid Tumor Assay for Lysate
Assay Overview MAN-10033
- Sample Prep (Nucleic Acids) MAN-10051
- Sample Prep (Protein ± RNA) MAN-10054
- Low-RNA Pre-Amplification (Optional) MAN-10046
- RNA:Protein Hybridization MAN-10060
Vantage 3D™ RNA:Protein Solid Tumor Assay For FFPE
Assay Overview MAN-10035
- Sample Prep (Nucleic Acids) MAN-10050
- Sample Prep (Protein) MAN-10053
- Low-RNA Pre-Amplification (Optional) MAN-10046
- RNA:Protein Hybridization MAN-10060
Click here to view how cancer cell profiling by barcoding allows multiplexed protein analysis in fine-needle aspirates.
Presented Posters:
| Product | Description | Catalog Number | Unit Size |
|---|---|---|---|
| nCounter® Vantage 3D™ RNA:Protein Solid Tumor for Lysates | 770 gene expression CodeSet (PanCancer Pathways), Antibody Mix for 28 solid tumor signaling protein targets. Protein TagSet (R) (no ERCC) for protein target detection. Buffer WS. Compatible with lysate samples. | VRPC-SPKP-HSTL-12 | 12 reactions |
| nCounter® Vantage 3D™ RNA:Protein Solid Tumor for FFPE | 770 gene expression CodeSet (PanCancer Pathways), 26 solid tumor signaling protein targets. Protein TagSet (R) (no ERCC) for protein target detection. Protein FFPE Sample Prep Kit, which contains Buffer W and Buffer T. Compatible with FFPE samples. Compatible with FFPE samples. | VRPC-SPKP-HSTF-12 | 12 reactions |
For Research Use Only. Not for use in diagnostic procedures.